Matches in Wikidata for { <http://www.wikidata.org/entity/Q98937138> ?p ?o ?g. }
- Q98937138 description "2020 nî lūn-bûn" @default.
- Q98937138 description "2020年の論文" @default.
- Q98937138 description "2020年学术文章" @default.
- Q98937138 description "2020年学术文章" @default.
- Q98937138 description "2020年学术文章" @default.
- Q98937138 description "2020年学术文章" @default.
- Q98937138 description "2020年学术文章" @default.
- Q98937138 description "2020年学术文章" @default.
- Q98937138 description "2020年學術文章" @default.
- Q98937138 description "2020年學術文章" @default.
- Q98937138 description "2020年學術文章" @default.
- Q98937138 description "2020年學術文章" @default.
- Q98937138 description "2020年學術文章" @default.
- Q98937138 description "2020년 논문" @default.
- Q98937138 description "article científic" @default.
- Q98937138 description "article scientific" @default.
- Q98937138 description "article scientifique" @default.
- Q98937138 description "articol științific" @default.
- Q98937138 description "articolo scientifico" @default.
- Q98937138 description "artigo científico" @default.
- Q98937138 description "artigo científico" @default.
- Q98937138 description "artigo científico" @default.
- Q98937138 description "artikel ilmiah" @default.
- Q98937138 description "artikull shkencor" @default.
- Q98937138 description "artikulong pang-agham" @default.
- Q98937138 description "artykuł naukowy" @default.
- Q98937138 description "artículo científico publicado en 2020" @default.
- Q98937138 description "artículu científicu" @default.
- Q98937138 description "bilimsel makale" @default.
- Q98937138 description "bài báo khoa học" @default.
- Q98937138 description "naučni članak" @default.
- Q98937138 description "scienca artikolo" @default.
- Q98937138 description "scientific article published on 03 September 2020" @default.
- Q98937138 description "scientific article published on 3 September 2020" @default.
- Q98937138 description "scientific article published on 3 September 2020" @default.
- Q98937138 description "teaduslik artikkel" @default.
- Q98937138 description "tieteellinen artikkeli" @default.
- Q98937138 description "tudományos cikk" @default.
- Q98937138 description "vedecký článok" @default.
- Q98937138 description "vetenskaplig artikel" @default.
- Q98937138 description "videnskabelig artikel udgivet 3. september 2020" @default.
- Q98937138 description "vitenskapelig artikkel" @default.
- Q98937138 description "vitskapeleg artikkel" @default.
- Q98937138 description "vědecký článek" @default.
- Q98937138 description "wetenschappelijk artikel" @default.
- Q98937138 description "wissenschaftlicher Artikel" @default.
- Q98937138 description "επιστημονικό άρθρο" @default.
- Q98937138 description "мақолаи илмӣ" @default.
- Q98937138 description "наукова стаття, опублікована у вересні 2020" @default.
- Q98937138 description "научна статия" @default.
- Q98937138 description "научная статья" @default.
- Q98937138 description "научни чланак" @default.
- Q98937138 description "научни чланак" @default.
- Q98937138 description "מאמר מדעי" @default.
- Q98937138 description "مقالة علمية نشرت في 3 سبتمبر 2020" @default.
- Q98937138 description "৩ সেপ্টেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q98937138 description "บทความทางวิทยาศาสตร์" @default.
- Q98937138 description "სამეცნიერო სტატია" @default.
- Q98937138 name "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 name "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 type Item @default.
- Q98937138 label "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 label "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 prefLabel "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 prefLabel "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 P1433 Q98937138-BCDF474D-BE5C-4C1F-89C2-68DA0F67316E @default.
- Q98937138 P1476 Q98937138-371813F6-BC17-41BD-A707-70C828ACC065 @default.
- Q98937138 P2093 Q98937138-0B26B1F6-F00A-4116-94CF-EA963FBBA027 @default.
- Q98937138 P2093 Q98937138-0B573DE6-65B8-48A6-AC20-1970D70E141D @default.
- Q98937138 P2093 Q98937138-17CE1CC5-5866-45EE-B41D-CF7B319BCD0B @default.
- Q98937138 P2093 Q98937138-1AEDD1E2-F82A-4870-AEF0-006BB6377488 @default.
- Q98937138 P2093 Q98937138-24A50F1E-B573-4896-9142-443FC61E9AEC @default.
- Q98937138 P2093 Q98937138-4F77E6D0-17DF-464E-88CB-22B6B93B900D @default.
- Q98937138 P2093 Q98937138-65AE8183-3BD1-46E5-B464-E90F0A2AA4BF @default.
- Q98937138 P2093 Q98937138-722AB8CA-C1E1-41FC-91C4-7DF73DEC2B77 @default.
- Q98937138 P2093 Q98937138-B55C0F6F-4927-4BCD-8AFB-5338D1DEEF33 @default.
- Q98937138 P2093 Q98937138-E0027F52-4927-4FD8-8E36-8FB96862580A @default.
- Q98937138 P2093 Q98937138-FF9D38C7-57B6-4F18-B623-48F507EBDCFF @default.
- Q98937138 P31 Q98937138-FB5F61F7-F99A-483C-819A-F66001AE0AD9 @default.
- Q98937138 P356 Q98937138-D6345592-A578-4A15-90A5-1839949AF597 @default.
- Q98937138 P50 Q98937138-1538AE89-2E8D-4C19-B251-7D2B1C0B216A @default.
- Q98937138 P50 Q98937138-1C166E75-0C06-4382-810E-0A6031A283DA @default.
- Q98937138 P50 Q98937138-2F5B1A83-46D3-4243-B5AB-62688CBD1C3E @default.
- Q98937138 P50 Q98937138-429B8EA1-CCBF-4A6E-AF0F-1F94490843EB @default.
- Q98937138 P50 Q98937138-6A1EB5C6-DA3F-4EBF-B8C6-752ACCBE84D5 @default.
- Q98937138 P50 Q98937138-813A7304-56A5-4B18-89E1-23750976AF36 @default.
- Q98937138 P50 Q98937138-B34BE0D4-243F-44F2-B786-187AF137595C @default.
- Q98937138 P50 Q98937138-E2DB9E34-6708-497F-A667-4424DFDA6621 @default.
- Q98937138 P50 Q98937138-E4D1170B-EAC2-4FDB-9186-C0AB438DC035 @default.
- Q98937138 P577 Q98937138-B5152B7C-8D06-40BC-BF77-48BBA7790597 @default.
- Q98937138 P698 Q98937138-7B8C9584-83B4-4AE9-A7A2-10E31DD95D79 @default.
- Q98937138 P921 Q98937138-E21B3B2E-3984-4BD0-8E1C-3E06918AAA40 @default.
- Q98937138 P921 Q98937138-F77DB51B-7DB7-4348-9BCF-5F2E1400F3E2 @default.
- Q98937138 P932 Q98937138-35E466EF-3669-4733-9039-E3184FEA20BE @default.
- Q98937138 P356 JAMAONCOL.2020.3524 @default.
- Q98937138 P698 32880602 @default.
- Q98937138 P1433 Q22079683 @default.
- Q98937138 P1476 "Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial" @default.
- Q98937138 P2093 "Beth Overmoyer" @default.
- Q98937138 P2093 "Chelsea Andrews" @default.